MedTrace Logo

Lidocaine Infusions for Rib Fractures

NCT03571919 · Status: WITHDRAWN · Phase: PHASE4 · Type: INTERVENTIONAL

Last updated 2021-06-28

No results posted yet for this study

Summary

Patients with traumatic rib fractures not receiving regional anesthesia through a epidural or nerve block catheter will be recruited for the study. Once enrolled, they will be randomized to receive either intravenous lidocaine or intravenous saline for control of pain related to their rib fractures. In addition, they will receive other pain medications, such as acetaminophen, gabapentin, and opioid pain medications. Our primary outcome is a decrease in their opioid medication requirements.

Conditions

  • Rib Fracture Multiple
  • Trauma Chest
  • Pain, Acute

Interventions

DRUG

Lidocaine infusion

Intravenous bolus of lidocaine (1.25 mg/kg) and then infusion at 1 mg/kg/hr

DRUG

Saline infusion

Intravenous bolus of saline and then infusion

Sponsors & Collaborators

Principal Investigators

  • Jeff Choi, MD · Stanford University

  • Michael Y Lin, MD · Stanford University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-06-15
Primary Completion
2019-06-01
Completion
2019-07-01
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03571919 on ClinicalTrials.gov